Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2005-05-24
2005-05-24
Guzo, David (Department: 1636)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S320100, C435S455000, C435S456000, C435S457000, C435S069100, C435S183000, C435S325000, C435S349000, C435S350000, C435S351000, C435S366000, C435S363000, C435S368000, C435S370000, C435S371000, C435S372000
Reexamination Certificate
active
06897045
ABSTRACT:
The invention provides an isolated and purified DNA molecule comprising at least one DNA segment, a biologically active subunit or variant thereof, of a circular intermediate of adeno-associated virus, which DNA segment confers increased episomal stability, persistence or abundance of the isolated DNA molecule in a host cell. The invention also provides a composition comprising at least two adeno-associated virus vectors.
REFERENCES:
patent: 5604090 (1997-02-01), Alexander et al.
patent: 5691176 (1997-11-01), Lebkowski et al.
patent: 5801030 (1998-09-01), McVey et al.
patent: 5834182 (1998-11-01), Alexander et al.
patent: 5843742 (1998-12-01), Natsoulis et al.
patent: 6083702 (2000-07-01), Mitchell et al.
patent: 6156303 (2000-12-01), Russell et al.
patent: 6200560 (2001-03-01), Couto et al.
patent: 6287569 (2001-09-01), Kipps et al.
patent: 6436392 (2002-08-01), Engelhardt et al.
patent: 6544786 (2003-04-01), Xiao et al.
patent: 20020131956 (2002-09-01), Walsh et al.
patent: 20030103939 (2003-06-01), Engelhardt et al.
patent: 9413788 (1992-12-01), None
patent: 9507351 (1993-09-01), None
patent: WO-9515384 (1995-06-01), None
patent: 9809657 (1996-09-01), None
patent: 9722250 (1996-12-01), None
patent: WO-9824479 (1998-06-01), None
patent: WO-0075365 (2000-12-01), None
patent: WO-0125465 (2001-04-01), None
patent: WO-0183692 (2001-11-01), None
patent: WO-03006616 (2003-01-01), None
“PCT International Search Report from International Application No. PCT/US02/21926”, (Oct. 15, 2002), 4 pages.
Bartlett, J S., et al., “Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody”,Nature Biotechnology,17, (1999),pp. 181-186.
Chu, Q , et al., “Binding and uptake of Cationic Lipid: pDNA Complexes by Polarized Airway Epithelial Cells”,Human Gene Therapy,10, (1999), pp. 25-36.
Coonrod, A, et al., “On the mechanism of DNA transfection: efficent gene transfer without viruses”,Gene Therapy,4, 1997),pp. 1313-1321.
Duan, Dongsheng , et al., “Dynamin is required for recombinant adeno-associated virus type 2 infection”,J of Virology,vol. 73, No. 12, XP002154342, (Dec. 1999), 10371-10376).
Duan, D , et al., “Response to “Polarity Influences the Efficiency of Recombinant Adenoassociated Virus Infection in Differentiated Airway Epithelia””,Human Gene Therapy,10, (1999),pp. 1553-1557.
Fasbender, Al , et al., “Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo”,The Journal of Biological Chemistry,272 (10), (Mar. 7, 1997),6479-6489.
Ferrari, F K., et al., “Second-Strand Synthesis Is a Rate Limiting Step for Efficient Transduction by Recombinant Adeno-Associated Virus Vectors”,Journal of Virology,70 (5), (1996),pp. 3227-3234.
Fisher, K J., et al., “Transduction with Recombinant Adeno-Associated Virus for Gene Therapy Is Limited by Leading-Strand Synthesis”,Journal of Virology,70 (1), (1996),pp. 520-532.
Gabizon, Alberto , “Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals”,Advanced Drug Delivery Reviews,(1997),337-344.
Gottlieb, T A., et al., “Actin Microfilaments Play a Critical Role in Endocytosis at the Apical but not the Basolateral Surface of Polarized Epithelial Cells”,The Journal of Cell Biology,120 (3), (1993),pp. 695-710.
Kaplan, Johanne M., et al., “Potentiation of gene transfer to the mouse lung by complexes of adenvirus vector and polycations improves therapeutic potential”,Human Gene Therapy,vol. 9, No. 10, XP000972242, (Jul. 1, 1998),1469-1479.
Lebkowski, J. , “Adeno-Associated Virus: a Vector System for Efficient Introduction and Integration of DNA into a Variety of Mammalian Cell Types”,Molecular and Cellular Biology,vol. 8, No. 10,(Oct. 1988),3988-3996.
Liang, E. , et al., “Oligonucleotide delivery: a cellular prospective”,Pharmazie,vol. 54, No. 8, XP000965598, (Aug. 1999),559-566.
Mah, C , et al., “Adeno-Associated Virus Type 2-Mediated Gene Transfer: Role of Epidermal Growth Factor Receptor Protein Tyrosine Kinase in Transgene Expression”,Journal of Virology,72 (12), (1998),pp. 9835-9843.
Pickles, R J., et al., “Limited Entry of Adenovirus Vectors into Well-Differentiated Airway Epithelium Is Responsible for Inefficient Gene Transfer”,Journal of Virology,72 (7), (1998),pp. 6014-6023.
Russell, D W., et al., “DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors”,PNAS,92, (1995),pp. 5719-5723.
Sanlioglu, S , et al., “Cellular redox state alters recombinant adeno-associated virus transduction through tyrosine phosphatase pathways”,Gene Therapy,6, (1999),pp. 1427-1437.
Teramoto, S. , et al., “Factors influencing adeno-associated virus-mediated gene transfer to human cystic fibrosis airway epithelial cells: comparison with adenovirus vectors”,J. ofVirology,vol. 72, No. 11, XP002154339, (Nov. 1998),8904-8912.
Vihinen-Ranta, M , et al., “Intracellular Route of Canine Parvovirus Entry”,Journal of Virology,72 (1), (1998),pp. 802-806.
Walters, R W., et al., “Basolateral Localization of Fiber Receptors Limits Adenovirus Infection from the Apical Surface of Airway Epithelia”,The Journal of Biological Chemistry,274 (15), (1999),pp. 10219-10226.
Wickham, T J., et al., “Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types”,Nature Biotechnology,14, (1996),pp. 1570-1573.
Wickham, T J., et al., “Targeted Adenovirus Gene Transfer to Endothelial and Smooth Muscle Cells by Using Bispecific Antibodies”,Journal of Virology,70 (10), (1996),pp. 6831-6838.
Xiao, W , et al., “Adeno-Associated Virus as a Vector for Liver-Directed Gene Threapy”,Journal of Virology,72 (12), (1998),pp. 10222-10226.
Yang, Jusan , et al., “Concatamerization of adeno-associated virus circular genomes occurs tghroug intermolecular recombination”,J. of Virology,73 (11), (Nov. 1999),pp. 9468-9477.
Zabner, J , et al., “Adenovirus-Mediated Gene Transfer to Ciliated Airway Epithelia Requires Prolonged Incubation Time”,Journal of Virology,70 (10), (1996),pp. 6994-7003.
Zabner, J , et al., “Adenovirus-mediated generation of cAMP-stimulated Cl-transport in cystic fibrosis airway epithelia in vitro: effect of promoter and administration method”,Gene Therapy,3, (1996),pp. 458-465.
Afione, S.A., et al., “In Vivo Model of Adeno-Associated Virus Vector Persistence and Rescue”,Journal of Virology,70 (5), pp. 3235-3241, (May 1996).
Ali, R.R., et al., “Gene transfer into the mouse retina mediated by an adeno-associated viral vector”,Human Molecular Genetics,5 (5), pp. 591-594, (1996).
Bennett, J., et al., “Real-Time, Noninvasive In Vivo Assessment of Adeno-Associated Virus-Mediated Retinal Transduction”,Investigative Ophthalmology&Visual Science,38 (13), pp. 2857-2863, (Dec. 1997).
Berns, K.I., “Parvovirus Replication”,Microbiological Reviews,54 (3), pp. 316-329, (Sep. 1990).
Berns, K.I., et al., “Biology of Adeno-associated Virus”, In:Current Topics in Microbiology and Immunology,218, Springer-Verlag, Berlin: R.W. Compans, et al., (Eds.), pp. 1-23, (1996).
Clark, K.R., et al., “Recombinant Adeno-Associated Viral Vectors Mediate Long-Term Transgene Expression in Muscle”,Human Gene Therapy,8, pp. 659-669, (Apr. 10, 1997).
Conrad, C.K., et al.,“Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung”,Gene Therapy,3, pp. 658-668, (1996).
Duan, D., et al., “Circular intermediates of recombinant adeno-associated virus having defined structural characteristics responsible for long-term episomal p
Duan Dongsheng
Engelhardt John F.
Guzo David
Schwegman Lundberg Woessner & Kluth P.A.
University of Iowa Research Foundation
LandOfFree
Adeno-associated virus vectors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adeno-associated virus vectors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adeno-associated virus vectors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3456067